Literature DB >> 18305113

The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum.

Malaiyalam Mariappan1, Santosh Lakshmi Gande, Karthikeyan Radhakrishnan, Bernhard Schmidt, Thomas Dierks, Kurt von Figura.   

Abstract

Formylglycine-generating enzyme (FGE) catalyzes the oxidation of a specific cysteine residue in nascent sulfatase polypeptides to formylglycine (FGly). This FGly is part of the active site of all sulfatases and is required for their catalytic activity. Here we demonstrate that residues 34-68 constitute an N-terminal extension of the FGE catalytic core that is dispensable for in vitro enzymatic activity of FGE but is required for its in vivo activity in the endoplasmic reticulum (ER), i.e. for generation of FGly residues in nascent sulfatases. In addition, this extension is needed for the retention of FGE in the ER. Fusing a KDEL retention signal to the C terminus of FGE is sufficient to mediate retention of an N-terminally truncated FGE but not sufficient to restore its biological activity. Fusion of FGE residues 1-88 to secretory proteins resulted in ER retention of the fusion protein. Moreover, when fused to the paralog of FGE (pFGE), which itself lacks FGly-generating activity, the FGE extension (residues 34-88) of this hybrid construct led to partial restoration of the biological activity of co-expressed N-terminally truncated FGE. Within the FGE N-terminal extension cysteine 52 is critical for the biological activity. We postulate that this N-terminal region of FGE mediates the interaction with an ER component to be identified and that this interaction is required for both the generation of FGly residues in nascent sulfatase polypeptides and for retention of FGE in the ER.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305113     DOI: 10.1074/jbc.M707858200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

2.  HpSumf1 is involved in the activation of sulfatases responsible for regulation of skeletogenesis during sea urchin development.

Authors:  Tetsushi Sakuma; Kazuya Ohnishi; Kazumasa Fujita; Hiroshi Ochiai; Naoaki Sakamoto; Takashi Yamamoto
Journal:  Dev Genes Evol       Date:  2011-06-27       Impact factor: 0.900

3.  Evaluation of sulfatase-directed quinone methide traps for proteomics.

Authors:  Janina Lenger; Marius Schröder; Eva C Ennemann; Benjamin Müller; Chi-Huey Wong; Thomas Noll; Thomas Dierks; Sarah R Hanson; Norbert Sewald
Journal:  Bioorg Med Chem       Date:  2011-04-24       Impact factor: 3.641

4.  Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Karthikeyan Radhakrishnan; Matthias Baumgartner; Regula Schmid; Bernhard Schmidt; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

5.  Proprotein convertases process and thereby inactivate formylglycine-generating enzyme.

Authors:  Eva C Ennemann; Karthikeyan Radhakrishnan; Malaiyalam Mariappan; Michaela Wachs; Thomas H Pringle; Bernhard Schmidt; Thomas Dierks
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

Review 6.  Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications.

Authors:  Mason J Appel; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

7.  Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion.

Authors:  Patrick G Holder; Lesley C Jones; Penelope M Drake; Robyn M Barfield; Stefanie Bañas; Gregory W de Hart; Jeanne Baker; David Rabuka
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

Review 8.  Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.

Authors:  Lars Schlotawa; Laura A Adang; Karthikeyan Radhakrishnan; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

9.  A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency.

Authors:  Orna Staretz-Chacham; Lars Schlotawa; Ohad Wormser; Inbal Golan-Tripto; Ohad S Birk; Carlos R Ferreira; Thomas Dierks; Karthikeyan Radhakrishnan
Journal:  Mol Genet Genomic Med       Date:  2020-02-12       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.